首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   125篇
  免费   6篇
  2021年   2篇
  2019年   1篇
  2018年   2篇
  2017年   2篇
  2016年   3篇
  2015年   7篇
  2014年   11篇
  2013年   6篇
  2012年   9篇
  2011年   10篇
  2010年   14篇
  2009年   2篇
  2008年   6篇
  2007年   1篇
  2006年   7篇
  2005年   3篇
  2004年   2篇
  2003年   5篇
  2002年   4篇
  2001年   2篇
  2000年   1篇
  1999年   3篇
  1998年   6篇
  1997年   2篇
  1996年   3篇
  1995年   1篇
  1994年   1篇
  1993年   2篇
  1992年   1篇
  1989年   1篇
  1988年   1篇
  1984年   2篇
  1983年   1篇
  1982年   1篇
  1980年   3篇
  1978年   1篇
  1941年   1篇
  1937年   1篇
排序方式: 共有131条查询结果,搜索用时 15 毫秒
71.
Despite efforts to develop concepts for efficient antibody fragment (Fab) production in Escherichia coli (E. coli) and the high degree of similarity within this protein class, a generic platform technology is still not available. Indeed, feasible production of new Fab candidates remains challenging. In this study, a setup that enables direct characterization of host cell response to Fab expression by utilizing genome‐integrated (GI) systems is established. Among the multitude of factors that influence Fab expression, the variable domain, the translocation mechanism, the host strain, as well as the copy number of the gene of interest (GOI) are varied. The resulting 32 production clones are characterized in carbon‐limited microbioreactor cultivations with yields of 0–7.4 mg Fab per gram of cell dry mass. Antigen‐binding region variations have the greatest effect on Fab yield. In most cases, the E. coli HMS174(DE3) strain performs better than the BL21(DE3) strain. Translocation mechanism variations mainly influence leader peptide cleavage efficiency. Plasmid‐free systems, with a single copy of the GOI integrated into the chromosome, reach Fab yields in the range of 80–300% of plasmid‐based counterparts. Consequently, the GI Fab production clones could greatly facilitate direct analyses of systems response to different impact factors under varying production conditions.  相似文献   
72.
Only a small fraction of the antibodies in a traditional polyclonal antibody mixture recognize the target of interest, frequently resulting in undesirable polyreactivity. Here, we show that high-quality recombinant polyclonals, in which hundreds of different antibodies are all directed toward a target of interest, can be easily generated in vitro by combining phage and yeast display. We show that, unlike traditional polyclonals, which are limited resources, recombinant polyclonal antibodies can be amplified over one hundred million-fold without losing representation or functionality. Our protocol was tested on 9 different targets to demonstrate how the strategy allows the selective amplification of antibodies directed toward desirable target specific epitopes, such as those found in one protein but not a closely related one, and the elimination of antibodies recognizing common epitopes, without significant loss of diversity. These recombinant renewable polyclonal antibodies are usable in different assays, and can be generated in high throughput. This approach could potentially be used to develop highly specific recombinant renewable antibodies against all human gene products.  相似文献   
73.
The great challenges for researchers working in the field of vaccinology are optimizing DNA vaccines for use in humans or large animals and creating effective single-dose vaccines using appropriated controlled delivery systems. Plasmid DNA encoding the heat-shock protein 65 (hsp65) (DNAhsp65) has been shown to induce protective and therapeutic immune responses in a murine model of tuberculosis (TB). Despite the success of naked DNAhsp65-based vaccine to protect mice against TB, it requires multiple doses of high amounts of DNA for effective immunization. In order to optimize this DNA vaccine and simplify the vaccination schedule, we coencapsulated DNAhsp65 and the adjuvant trehalose dimycolate (TDM) into biodegradable poly (DL-lactide-co-glycolide) (PLGA) microspheres for a single dose administration. Moreover, a single-shot prime-boost vaccine formulation based on a mixture of two different PLGA microspheres, presenting faster and slower release of, respectively, DNAhsp65 and the recombinant hsp65 protein was also developed. These formulations were tested in mice as well as in guinea pigs by comparison with the efficacy and toxicity induced by the naked DNA preparation or BCG. The single-shot prime-boost formulation clearly presented good efficacy and diminished lung pathology in both mice and guinea pigs.  相似文献   
74.
Induced by global warming, mountain plant species are migrating upwards. Species inhabiting the nival zone of today are threatened by competitors which move from the alpine zone towards the summits. The manner in which species move depends on their abilities to cope with microtopographical situations. We present a spatially explicit predictive model which draws scenarios of future species distribution patterns at a typical high mountain of the European Alps. The altitudinal temperature gradient is examined. Based on the lapse rate and on definitions of topographical niches of species, a +1 °C- and a +2 °C-warming scenario are modelled using a fine-scaled digital elevation model. Nival species will lose area and become restricted to specific topographical situations. Alpine and subnival grassland species are predicted to expand their area, mainly along stable surface situations. Whether the migration will take place as a filling or a moving process is specific to the particular species. Overall, biodiversity is apparently not threatened on the decadal scale. In special cases, however, genetic losses are likely both on a local and on a regional scale.  相似文献   
75.
To create a tool for eukaryotic surface display, this approach is aimed at demonstrating a direct modification of the native envelope protein gp64 of Autographa californica NPV without disturbing viral infectivity. Short affinity-tag peptides, the biotin mimic streptagII, and the gp41 amino-acid motif ELDKWA of HIV-1, specific for the human monoclonal antibody 2F5, were engineered into the baculovirus major coat protein gp64 and presented on the viral surface. Two different streptag peptides were inserted at the naturally occurring NotI site at amino-acid 278 of gp64. Additionally, the ten-amino-acid peptide GG-ELDKWA-GG, containing the epitope of mAb 2F5, was introduced into gp64 envelope protein at the same position. In all cases we were able to propagate viable virus-achieving infectious titers in the range of wild-type AcMNPV. Streptag and ELDKWA-epitope surface localization on purified virus particles was demonstrated by flow cytometry and Western blot analysis. We could also show selective retention of mutant viruses by specific interaction between chimeric virions and their target counterparts, recognizing the epitope or the streptag peptide in the viral envelope. These data provide evidence that altering the surface properties of the baculovirus virion could be of value in improving baculovirus display technology and developing new applications.  相似文献   
76.
77.
78.
79.
In recent years there has been an increase in both availability and demand for therapeutic monoclonal antibodies. Currently, most of these antibodies are produced by stably transfected mammalian cells. In this study we evaluated the use of different baculoviral insect cell systems as an alternative for commonly used production schemes. We expressed the human anti-gp41 antibody 3D6 in Spodoptera frugiperda Sf9, Trichoplusia ni BTI-TN5B1-4 "High Five", and Spodoptera frugiperda SfSWT-1 "Mimic?" insect cells and compared product yield, specificity and glycosylation patterns with a 3D6 antibody expressed in Chinese hamster ovary cells. Using "High Five" cells we achieved amounts of secreted antibody comparable to those resulting from transient expression in mammalian cells. We determined the N-linked oligosaccharide structures present on asparagine-297 in IgG? heavy chains and tested the functionality in terms of antigen binding and the ability to elicit effector functions. Antibodies expressed in all insect cell lines displayed highly specific antigen binding. In general, the insect-produced antibodies carried, as the CHO-produced form, fucosylated N-glycans, including, in the case of "High Five" cells, high levels of core α1,3-fucose. This indicates that in all systems glycoengineering may be required in order to produce optimal glycoforms of this antibody.  相似文献   
80.
This study provides a first country-wide overview of the vertical distribution patterns and the chorology of vascular plant species that occur in the uppermost elevation zones in Iran. The current distribution patterns are discussed with respect to potential warming-induced species losses. Iran’s subnival and nival vegetation zones are found at elevations above 3600–3900 m in a highly fragmented distribution across Alborz, Zagros, and NW-Iran. Based on literature research and on field observations, all vascular plant species living in the subnival–nival zone of Iranian mountains were identified (151 species) and classified into three altitudinal groups: Group A comprises species that occur mainly in subnival–nival habitats (51 species). Group B are species being common in subnival–nival areas but are equally present in the alpine zone (56 species). Group C are species that can reach to subnival areas but also grow in alpine, subalpine and sometimes lower altitudes (44 species). The chorological patterns differ among the three groups. The percentage of species being endemic to Iran decreases from group A, to B and C, with 68, 53 and 20%, respectively. A narrow altitudinal distribution at high elevations is clearly related to a small-scaled geographical distribution range. The outstanding rate of high-altitude endemism appears to result mainly from orographic isolation of the country’s highly scattered cold areas and by the absence of extensive Pleistocene glaciations. The narrow distribution of most of Iran’s cold-adapted mountain flora and the low potential of alternative cold habitats render it highly vulnerable to climate change.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号